Asymchem Laboratories Tianjin Co (SZSE:002821) Net Income From Continuing Operations : ¥1,902 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Asymchem Laboratories Tianjin Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥280 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,902 Mil.

Asymchem Laboratories Tianjin Co Net Income From Continuing Operations Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Net Income From Continuing Operations Chart

Asymchem Laboratories Tianjin Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

553.86

722.05

1,069.26

3,294.63

2,250.82

Asymchem Laboratories Tianjin Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															627.89	1,054.10	518.82	50.01	279.53

Asymchem Laboratories Tianjin Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,902 Mil.

Asymchem Laboratories Tianjin Co (SZSE:002821) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

06821:Hong Kong 7K90:Germany

Address

No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457

Website

https://www.asymchem.com

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development Manufacture Organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of global pharmaceutical technology.

Executives

Xiao Yi	Executives
Xu Xiang Ke	Directors, executives
Zhou Yan	Executives
Chen Chao Yong	Executives
Huang Xiao Lian	Executives
Yang Jing	Director
	Executives

Asymchem Laboratories Tianjin Co (SZSE:002821) Headlines

No Headlines